Genetic association studies of tumour necrosis factor α and β and tumour necrosis factor receptor 1 and 2 polymorphisms across the clinical spectrum of multiple sclerosis

Journal of Neurology

Volumn 246, Issue 11, 1999, Pages 1051-1058

  McDonnell, Gavin V ^a   Kirk, Claire W ^b   Middleton, Derek ^b,c   Droogan, Aidan G ^a   Hawkins, Stanley A ^c,d   Patterson, Chris C ^c   Graham, Colin A ^b  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d Northern Ireland Regional Genetics Service   (United Kingdom)

Author keywords

Association studies; Multiple sclerosis; Primary progressive; Tumour necrosis factor; Tumour necrosis factor receptor

Indexed keywords

GADOLINIUM; HLA DR ANTIGEN; LYMPHOTOXIN; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; BLOOD LEVEL; COMPUTER PROGRAM; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGRESSION ANALYSIS;

ADULT; ALLELES; FEMALE; HUMANS; LYMPHOTOXIN-ALPHA; MALE; MICROSATELLITE REPEATS; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS; RECEPTORS, TUMOR NECROSIS FACTOR; REGRESSION ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032707492     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050511     Document Type: Article

References (36)

1. 1. Aggarwal BB, Eessalu TE, Hass PE (1985) Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon. Nature 318:665-667
2. 2. Baglioni C, McCandless S, Tavernier J, Fiers W (1985) Binding of human tumor necrosis factor to high affinity receptors on HeLa and lymphoblastoid cells sensitive to growth inhibition. J Biol Chem 260:13395-13397
3. 3. Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H (1990) Identification of two types of tumour necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 87:3127-3131
4. 4. Confavreux C, Aimard G, Devic M (1980) Course and prognosis of multiple sclerosis assessed by the computerised data processing of 349 patients. Brain 103:281-300
5. 5. Epplen C, Jäckel S, Santos EJM, D'Souza M, Poehlau D, Dotzauer B, Sindern E, Haupts M, Rüde KP, Weber F, Stöver J, Poser S, Gehler W, Malin JP, Przuntek H, Epplen JT (1997) Genetic predisposition to multiple sclerosis as revealed by immunoprinting. Ann Neurol 41:341-352
6. 6. Garcia-Merino A, Alper CA, Usuku K, Marcus-Bagley D, Lincoln R, Awdeh Z, Yunis EJ, Eisenbarth GS, Brink SJ, Hauser SL (1996) Tumour necrosis factor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretion. Hum Immunol 50: 11-21
7. 7. Giovannoni G, Thorpe JW, Kidd D, Kendall BE, Moseley IF, Thompson AJ, Keir G, Miller DH, Feldmann M, Thompson EJ (1996) Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease. J Neurol Neurosurg Psychiatry 60:20-26
8. 8. Glabinski A, Mirecka M, Pokoca L (1995) Tumour necrosis factor alpha but not lymphotoxin is overproduced by blood mononuclear cells in multiple sclerosis. Acta Neurol Scand 91:276-279
9. 9. He B, Navikas V, Lundahl J, Söderstrom M, Hillert J (1995) Tumor necrosis factor α-308 alleles in multiple sclerosis and optic neuritis. J Neuroimmunol 63:143-147
10. 10. Hillert J, Grönning M, Nyland H, Link H, Olerup O (1992) An immunogenetic heterogeneity in multiple sclerosis. J Neurol Neurosurg Psychiatry 55: 887-890
11. 11. Hofman FM, Hinton DR, Johnson K, Merrill JE (1989) Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170:607-612
12. 12. Hohmann H-P, Remy R, Brockhaus M, van Loon APGM (1989) Two different cell types have different major receptors for human tumor necrosis factor (TNFα). J Biol Chem 64:14927-14934
13. 13. Kirk CW, Droogan AG, Hawkins SA, McMillan SA, Nevin NC, Graham CA (1997) Tumour necrosis factor microsatellites show association with multiple sclerosis. J Neurol Sci 147: 21-25
14. 14. Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 46:907-911
15. 15. Matsuda M, Tsukada N, Miyagi K, Yanagisawa N (1994) Increased levels of soluble tumor necrosis factor receptor in patients with multiple sclerosis and HTLV-1-associated myelopathy. J Neuroimmunol 52:33-40
16. 16. McDonnell GV, Hawkins SA (1998) An epidemiologic study of multiple sclerosis in Northern Ireland. Neurology 50:423-428
17. 17. McDonnell GV, McMillan SA, Douglas JP, Droogan AG, Hawkins SA (1998) Raised CSF levels of soluble adhesion molecules across the clinical spectrum of multiple sclerosis. J Neuroimmunol 85:186-192
18. 18. Minderhoud JM, van der Hoeven JH, Prange AJA (1988) Course and prognosis of chronic progressive multiple sclerosis. Acta Neurol Scand 78:10-15
19. 19. Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP, Madani H, Widmer MB (1993) Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 151:1548-1561
20. 20. Olerup O, Hillert J, Fredrikson S, Olsson T, Kam-Hansen S, Möller E, Carlsson B, Wallin J (1989) Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci USA 86:7113-7117
21. 21. Pociot F, Briant L, Jongeneel CV, Mölvig J, Worsaae H, Abbal M, Thomsen M, Nerup J, Cambon-Thomsen A (1993) Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNFα and TNFβ by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 23: 224-231
22. 22. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231
23. 23. Revesz T, Kidd D, Thompson AJ, Barnard RO, McDonald WI (1994) A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain 117:759-765
24. 24. Rieckmann P, Martin S, Weichselbraun I, Albrecht M, Kitze B, Weber T, Tumani H, Broocks A, Lüer W, Helwig A, Poser S (1994) Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse. Neurology 44:2367-2372
25. 25. Roth M-P, Nogueira L, Coppin H, Clanet M, Clayton J, Carnbon-Thomsen A (1994) Tumor necrosis factor polymorphisms in multiple sclerosis: no additional association independent of HLA. J Neuroimmunol 51:93-99
26. 26. Sandberg-Wollheim M, Ciusani E, Salmaggi A, Pociot F (1995) An evaluation of tumor necrosis factor microsatellite alleles in genetic susceptibility to multiple sclerosis. Mult Scler 1:181-185
27. 27. Selmaj KW, Farooq M, Norton WT, Raine CS, Brosnan CF (1990) Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J Immunol 144:129-135
28. 28. Selmaj K, Papierz W, Glabinski A, Kohno T (1995) Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J Neuroimmunol 56:135-141
29. 29. Selmaj KW, Raine CS (1988) Tumour necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23:339-346
30. 30. Selmaj K, Raine CS, Cannella B, Brosnan CF (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87:949-954
31. 31. Thompson AJ, Kermode AG, MacManus DG, Kendall BE, Kingsley DPE, Moseley IF, McDonald WI (1990) Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. BMJ 300:631-634
32. 32. Thompson AJ, Kermode AG, Wicks D, MacManus DG, Kendall BE, Kingsley DPE, McDonald WI (1991) Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 29:53-62
33. 33. Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turetskaya RL (1993) Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 16:180-186
34. 34. Weinshenker BG, Santrach P, Bissonet AS, McDonnell SK, Schaid D, Moore SB, Rodriguez M (1998) Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology 51: 742-747
35. 35. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci USA 94:3195-3199
36. 36. Wingerchuk D, Liu Q, Sobell J, Sommer S, Weinshenker BG (1997) A population-based case-control study of the tumor necrosis factor alpha-308 polymorphism in multiple sclerosis. Neurology 49:626-628